Auto-Injectors Market Scenario:
Auto-injectors are medical devices designed to deliver a precise single dose of a drug with minimal human intervention thereby are easy to use and are intended for self-administration by untrained patients. The global market for auto-injectors is projected to reach USD 2.4 billion at a CAGR of 17.2 % by the end of the forecasted period.
Auto-Injectors Market Dynamics:
Benefits of auto-injectors such as reduction of anxiety and hesitation associated with self-administration of the needle-based drug delivery devices, precise drug dose delivery, and growing incidence of chronic diseases such as diabetes, anaphylaxis, food allergies and arthritis are the prime drivers of the market. Diabetes represents a strong market opportunity. According to the World Health Organization type-2 diabetes cases are expected to rise to a staggering 438 million by 2030 from 285 million people in 2015. The rise is expected to be in developing regions such as India, which is already the diabetes capital of the world with as many as 50 million diabetes patients. The number is expected to reach 87 million patients by 2030. The International Diabetes Federation estimates a 420 million adult diabetic population in 2016, which is increasing at the rate of 8.4% and is anticipated to reach 625 million by 2040.
Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/2046 .
Growth in risk factors such as increasing obese population, sedentary lifestyles, sugar-rich foods, lack of exercise is other drivers as they indirectly contribute to the growing pool of the patients. The support provided by governments is analogous to the icing on the cake. For example, the New National Health Policy 2017 (NHP) of India aims to reduce the mortality from diabetes by 25% by 2025.
The high premium over the cost of auto-injectors has led to strong market rivalry over epinephrine auto-injector cost by different brands attracting new players to the market.
The high cost of the devices, lack of awareness and consolidated nature of the market are the restraints on growth.
Auto-Injectors Market Prominent Players:
Some of the dominant players in this market are Enbrel, UNILIFE CORPORATION, Amedra Pharmaceuticals LLC, Owen Mumford Ltd. (UK), Scandinavian Health Ltd, kaleo, Inc., and others.
Auto-Injectors Market Segments:
To generate a bird’s view of the market the global auto-injectors market has been segmented by product type, application, suppliers, and regions.
Based on product type, the market is segmented as reusable, disposable, and others.
Based on application, the market is segmented as multiple sclerosis, anaphylaxis, allergies, rheumatoid arthritis and others.
Based on suppliers, the market is segmented as pharmacy, online retailers, retailers and others.
Based on regions, the market is segmented as North America, Europe, Asia Pacific, Middle East and Africa.
Auto-Injectors Market Regional Analysis:
North America led by the U.S. accounts for the largest Auto-Injectors Market owing to high disposable income, the presence of large players, excellent reimbursement and developed healthcare infrastructure. The North American auto-injectors market is projected to reach at USD 0.9 billion by the end of the review period of 2016 to 2022.
Europe led by Germany, France, and U.K. is the second-largest market for auto-injectors. The large medical device industry of Germany is a strong determinant for its dominance of the European market. Asia Pacific region led by China and India is expected to be the fastest growing region in auto-injectors market. However, Japan accounts for the largest market share of the Asia Pacific region in 2016.
The Middle East and Africa region are anticipated to be dominated by Gulf economies of Saudi Arabia, UAE, Kuwait, and Qatar.
December 2016 – Mylan N.V. launched generic epinephrine injection “EpiPen” auto-injector at a wholesale acquisition cost of USD 300 per two-pack epinephrine injection. EpiPen has been priced 50 % lower than the WAC of EpiPen 2-Pak Auto-Injectors. The move is aimed to quell the backlash over the branded product’s steep price.
August 2017 – The Kaléo, pharmaceutical company, announced its latest charitable product donation program, “Q Your School,” offering AUVI-Q epinephrine injection auto-injectors free of charge to all public elementary schools in the United States.
Major TOC Auto-Injectors Market Research Report- Global Forecast to 2022:
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat of New Entrants
Get Your Customized Report @ https://www.marketresearchfuture.com/enquiry/2046 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312